Chromium (Hospira, Inc.)


Welcome to the PulseAid listing for the Chromium drug offered from Hospira, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: Chromic Chloride
SUBSTANCE NAME: CHROMIC CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-04-27
END MARKETING DATE: 0000-00-00


Chromium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionChromium from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 4(ug/mL)
START MARKETING DATE: 2016-04-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-4093_18f76470-71f2-4a35-912a-cd923bfa6520
PRODUCT NDC: 0409-4093
APPLICATION NUMBER: NDA018961

Other CHROMIC CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.Chromium